While health agencies have issued travel alerts regarding France's Department of La Réunion Chikungunya outbreak for years, cases have spiked substantially since early 2025.
As of February 18, 2025, and since August 23, 2024, ARS Reunion confirmed 1,069 indigenous (local) cases recorded, including 927 since January 1, 2025.
The municipalities of Étang-Salé and Le Tampon have the most Chikungunya virus (CHIKV) cases, with 228 and 169 cases, respectively.
Level 2 Travel Alert Issued for France's La Réunion Chikungunya Outbreak
Can Fractional Yellow Fever Vaccinations Decrease Deaths in the Americas
While the Yellow fever vaccine has been found highly effective when administered as a single dose, researchers have continued to examine the minimum dose requirements for seroconversion.
These researchers say the potential advantages of offering fractional doses are increased vaccinations and reduced under-vaccination, which have become a measurable health concern in the Region of the Americas over the past few years.
For example, 61 human cases of yellow fever were confirmed in the Region of the Americas in 2024, of which 30 were fatal (case fatality ratio, 50%).
Acalabrutinib-Venetoclax Prolongs Survival in Previously Untreated Leukemia
Progression-free survival significantly lower with fixed-duration acalabrutinib-venetoclax with or without obinutuzumab
Postpandemic Hospital Occupancy Up to 73.5 Percent, Sparking Concern
National hospital occupancy of about 85 percent expected by 2032 for adult beds, by 2035 for adult and pediatric beds combined
New York Sues Vape Companies for Marketing to Youth, Violating Flavor Ban
By India Edwards HealthDay ReporterFRIDAY, Feb. 21, 2025 (HealthDay News) — New York Attorney General Letitia James filed a major lawsuit yesterday, accusing 13 e-cigarette companies of illegally selling flavored …